Teva Investigational Site 12130 — Pell City, Alabama

Teva Investigational Site 12130 is a clinical research site located in Pell City, Alabama, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 12130 has participated in 1 clinical trials.

Therapeutic areas: Persistent Asthma.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pell City

Browse all research sites in Alabama · View every site in Pell City

• Research Site
• Pfizer Investigational Site
• GSK Investigational Site
• Alabama Clinical Research Associates
• Novo Nordisk Investigational Site
• Furiex Research Site
• Forest Investigative Site 1353
• Advanced Clinical Research 1000 Forrest Place Suite 2 Pell City
• Advanced Clinical Research
• Site Reference ID/Investigator# 46345
• Research Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 12130?

Teva Investigational Site 12130 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 12130 conducted?

Teva Investigational Site 12130 has 1 clinical trials on record. Their work covers Persistent Asthma.

Is Teva Investigational Site 12130 accredited by Crixeo Clinical Trials?

Teva Investigational Site 12130 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 12130?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.